Nicotine

Generic Name
Nicotine
Brand Names
Habitrol, Nicoderm C-Q, Nicorelief, Nicorette, Nicotrol
Drug Type
Small Molecule
Chemical Formula
C10H14N2
CAS Number
54-11-5
Unique Ingredient Identifier
6M3C89ZY6R
Background

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

Indication

For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.

Associated Conditions
Withdrawal Nicotine
Associated Therapies
Smoking cessation therapy

Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans

Early Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-02-15
Last Posted Date
2014-07-08
Lead Sponsor
Yale University
Target Recruit Count
18
Registration Number
NCT00616746
Locations
🇺🇸

VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States

Nicotine and Behavior in Adult ADHD

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2007-12-14
Last Posted Date
2011-09-09
Lead Sponsor
University of California, Irvine
Target Recruit Count
78
Registration Number
NCT00573248
Locations
🇺🇸

Department of Pediatrics, Irvine, California, United States

Study of Nicotine for the Prevention of PONV

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2007-11-04
Last Posted Date
2009-09-29
Lead Sponsor
University Hospital, Geneva
Target Recruit Count
200
Registration Number
NCT00553709
Locations
🇨🇭

Division of Anesthesiology, Geneva University Hospitals, Geneva, Switzerland

Analysis of Aldehyde Biomarkers of Exposure and Host Response

First Posted Date
2007-06-05
Last Posted Date
2023-09-07
Lead Sponsor
University of Nebraska
Target Recruit Count
35
Registration Number
NCT00482690
Locations
🇺🇸

Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Validation of Biomarkers of Exposure and Host Response

Not Applicable
Completed
Conditions
First Posted Date
2007-05-02
Last Posted Date
2023-08-31
Lead Sponsor
University of Nebraska
Target Recruit Count
60
Registration Number
NCT00468234
Locations
🇺🇸

University of Nebraska Medical Center, Omaha, Nebraska, United States

Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers

First Posted Date
2007-01-31
Last Posted Date
2007-01-31
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
40
Registration Number
NCT00429208
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

Nicotine as an Adjuvant Analgesic for Third Molar Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2006-10-09
Last Posted Date
2020-11-24
Lead Sponsor
Columbia University
Target Recruit Count
20
Registration Number
NCT00385216
Locations
🇺🇸

Columbia University, New York, New York, United States

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

First Posted Date
2006-02-28
Last Posted Date
2020-06-16
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
650
Registration Number
NCT00297479
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma

Phase 2
Completed
Conditions
First Posted Date
2006-02-24
Last Posted Date
2013-06-20
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
24
Registration Number
NCT00295984
Locations
🇺🇸

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath